Kang Jin Gu, Kim Jin Kyoung, Jeong Han-Sin, Jung Soo-Chan, Ko Moon Hee, Park Shin Hong, Cho Jae Keun, Lee Gil Joon, Choi Ji Won, Lee Byung Dal
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50, Irwon-dong, Gangnam-gu, Seoul, 135-710, Korea.
Anesth Analg. 2008 Jun;106(6):1723-7. doi: 10.1213/ane.0b013e3181730063.
One of the goals of anesthesia for laryngeal microsurgery is to provide a clear surgical view, and therefore anesthetics that produce less saliva are desirable. Sevoflurane inhalation anesthesia and total IV anesthesia with propofol/remifentanil are widely used for anesthesia during laryngeal microsurgery; however, few rigorous comparisons of the effects of sevoflurane and propofol/remifentanil on salivation have been performed.
Forty subjects undergoing laryngeal microsurgery were randomly assigned for sevoflurane or propofol/remifentanil anesthesia. We prospectively compared the salivary flow rates, compositions, the number of suction episodes required to clearly view the laryngeal lesions before the main procedures, and residual secretion volume after the procedure in both groups.
The mean salivary excretion rate was significantly higher in the propofol/remifentanil group than in the sevoflurane group (0.53 +/- 0.39 vs 0.28 +/- 0.15 mL/min, P < 0.001). Before starting the main procedure, the number of suction episodes required to clearly view the laryngeal lesions was also higher in the propofol/remifentanil group (5.0 +/- 2.3 vs 2.1 +/- 1.5, P < 0.001). Mean residual secretion in the oral cavity and oropharynx after the procedure was greater in the propofol/remifentanil group (2.13 +/- 0.59 vs 0.45 +/- 0.32 mL, P < 0.001). In addition, a significant difference in chloride levels in collected secretion was noted (sevoflurane; 93 +/- 19 vs propofol/remifentanil; 135 +/- 58 U/L, P = 0.004).
Salivary excretion under propofol/remifentanil anesthesia is greater than under sevoflurane anesthesia during laryngeal surgery.
喉显微手术麻醉的目标之一是提供清晰的手术视野,因此,产生较少唾液的麻醉剂较为理想。七氟烷吸入麻醉和丙泊酚/瑞芬太尼全静脉麻醉在喉显微手术麻醉中广泛应用;然而,很少有关于七氟烷和丙泊酚/瑞芬太尼对唾液分泌影响的严格比较研究。
40例行喉显微手术的患者被随机分配接受七氟烷或丙泊酚/瑞芬太尼麻醉。我们前瞻性地比较了两组患者的唾液流速、成分、在主要手术前清晰观察喉部病变所需的吸引次数以及手术后的残余分泌物量。
丙泊酚/瑞芬太尼组的平均唾液排泄率显著高于七氟烷组(0.53±0.39 vs 0.28±0.15 mL/分钟,P<0.001)。在开始主要手术前,丙泊酚/瑞芬太尼组清晰观察喉部病变所需的吸引次数也更多(5.0±2.3 vs 2.1±1.5,P<0.001)。丙泊酚/瑞芬太尼组手术后口腔和口咽的平均残余分泌物更多(2.13±0.59 vs 0.45±0.32 mL,P<0.001)。此外,收集的分泌物中氯水平存在显著差异(七氟烷组;93±19 vs丙泊酚/瑞芬太尼组;135±58 U/L,P = 0.004)。
在喉手术中,丙泊酚/瑞芬太尼麻醉下的唾液分泌量大于七氟烷麻醉下的唾液分泌量。